Abstract：
We describe a 9-year-old boy who developed generalised erythematous lesions 12 months after haematopoietic stem cell transplant (HSCT). Histopathology showed both features of psoriasis and graft-versus-host disease (GVHD). The lesions responded well to secukinumab, suggesting that IL-17A monoclonal antibody might be a treatment option for GVHD.
摘要：
我们描述了一个9岁的男孩，他在造血干细胞移植（HSCT）后12个月出现了全身性红斑病变。组织病理学显示银屑病和移植物抗宿主病（GVHD）的特征。病变对苏金单抗反应良好，提示IL-17A单克隆抗体可能是GVHD的治疗选择。
